Onconic Therapeutics unveiled OCN-501, a first-in-class candidate given with GLP-1 obesity drugs to preserve muscle, with ...
WALTHAM - Zenas BioPharma, Inc. ('Zenas' or the 'Company') (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company advancing therapies for patients living with autoimmun ...
Igloo will shut down its Abstract blockchain on Dec. 15 after losing tens of millions of dollars funding the Ethereum layer-2 network. Users must move their assets before the shutdown or risk losing ...
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced three-year follow-up results from the ovarian cancer cohort of its 400+ patient Phase 1b C-800-01 trial. The study ...
From the history of inheritance to design that accepts changeIs object-oriented programming necessary now that AI can write ...
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company ...
Many animals benefit from microbial symbionts that aid digestion, supply essential nutrients, or provide defense. When this ...
Erlang: a programming language built in a Swedish telecom lab in the 1980s, ended up running the biggest messaging app WhatsApp. Told by its co-creator.
"Is it really educational if they're just playing Roblox?"In interviews in Ginowan, I still hear this question often. Whether ...
Being female or a person of color has long been seen as a disadvantage in hiring and promotion. A new study of college professors shows that class may loom as large. By Noam Scheiber When Clint Harris ...
The conference schedule includes time for scientific presentations, as well as a virtual poster session for submitted abstracts. Top abstracts will be selected for Stellar Abstract Awards and will be ...
The 2025 Programme for International Student Assessment (PISA) results should concern the health community.1 PISA does not measure health literacy directly, but it assesses several cognitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results